Cargando…

Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins

Primary human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimers [(gp120/gp41)(3)] typically exist in a metastable closed conformation (state 1). Binding the CD4 receptor triggers Env to undergo extensive conformational changes to mediate virus entry. We identified specific gp120 res...

Descripción completa

Detalles Bibliográficos
Autores principales: Herschhorn, Alon, Ma, Xiaochu, Gu, Christopher, Ventura, John D., Castillo-Menendez, Luis, Melillo, Bruno, Terry, Daniel S., Smith, Amos B., Blanchard, Scott C., Munro, James B., Mothes, Walther, Finzi, Andrés, Sodroski, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080382/
https://www.ncbi.nlm.nih.gov/pubmed/27795397
http://dx.doi.org/10.1128/mBio.01598-16
_version_ 1782462700491636736
author Herschhorn, Alon
Ma, Xiaochu
Gu, Christopher
Ventura, John D.
Castillo-Menendez, Luis
Melillo, Bruno
Terry, Daniel S.
Smith, Amos B.
Blanchard, Scott C.
Munro, James B.
Mothes, Walther
Finzi, Andrés
Sodroski, Joseph
author_facet Herschhorn, Alon
Ma, Xiaochu
Gu, Christopher
Ventura, John D.
Castillo-Menendez, Luis
Melillo, Bruno
Terry, Daniel S.
Smith, Amos B.
Blanchard, Scott C.
Munro, James B.
Mothes, Walther
Finzi, Andrés
Sodroski, Joseph
author_sort Herschhorn, Alon
collection PubMed
description Primary human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimers [(gp120/gp41)(3)] typically exist in a metastable closed conformation (state 1). Binding the CD4 receptor triggers Env to undergo extensive conformational changes to mediate virus entry. We identified specific gp120 residues that restrain Env in state 1. Alteration of these restraining residues destabilized state 1, allowing Env to populate a functional conformation (state 2) intermediate between state 1 and the full CD4-bound state (state 3). Increased state 2 occupancy was associated with lower energy barriers between the states. State 2 was an obligate intermediate for all transitions between state 1 and state 3. State 2-enriched Envs required lower CD4 concentrations to trigger virus entry and more efficiently infected cells expressing low levels of CD4. These Envs were resistant to several broadly neutralizing antibodies and small-molecule inhibitors. Thus, state 2 is an Env conformation on the virus entry pathway; sampling state 2 increases the adaptability of HIV-1 to different host cell receptor levels and immune environments. Our results provide new insights into the conformational regulation of HIV-1 entry.
format Online
Article
Text
id pubmed-5080382
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-50803822016-10-27 Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins Herschhorn, Alon Ma, Xiaochu Gu, Christopher Ventura, John D. Castillo-Menendez, Luis Melillo, Bruno Terry, Daniel S. Smith, Amos B. Blanchard, Scott C. Munro, James B. Mothes, Walther Finzi, Andrés Sodroski, Joseph mBio Research Article Primary human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimers [(gp120/gp41)(3)] typically exist in a metastable closed conformation (state 1). Binding the CD4 receptor triggers Env to undergo extensive conformational changes to mediate virus entry. We identified specific gp120 residues that restrain Env in state 1. Alteration of these restraining residues destabilized state 1, allowing Env to populate a functional conformation (state 2) intermediate between state 1 and the full CD4-bound state (state 3). Increased state 2 occupancy was associated with lower energy barriers between the states. State 2 was an obligate intermediate for all transitions between state 1 and state 3. State 2-enriched Envs required lower CD4 concentrations to trigger virus entry and more efficiently infected cells expressing low levels of CD4. These Envs were resistant to several broadly neutralizing antibodies and small-molecule inhibitors. Thus, state 2 is an Env conformation on the virus entry pathway; sampling state 2 increases the adaptability of HIV-1 to different host cell receptor levels and immune environments. Our results provide new insights into the conformational regulation of HIV-1 entry. American Society for Microbiology 2016-10-25 /pmc/articles/PMC5080382/ /pubmed/27795397 http://dx.doi.org/10.1128/mBio.01598-16 Text en Copyright © 2016 Herschhorn et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Herschhorn, Alon
Ma, Xiaochu
Gu, Christopher
Ventura, John D.
Castillo-Menendez, Luis
Melillo, Bruno
Terry, Daniel S.
Smith, Amos B.
Blanchard, Scott C.
Munro, James B.
Mothes, Walther
Finzi, Andrés
Sodroski, Joseph
Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
title Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
title_full Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
title_fullStr Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
title_full_unstemmed Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
title_short Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
title_sort release of gp120 restraints leads to an entry-competent intermediate state of the hiv-1 envelope glycoproteins
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080382/
https://www.ncbi.nlm.nih.gov/pubmed/27795397
http://dx.doi.org/10.1128/mBio.01598-16
work_keys_str_mv AT herschhornalon releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT maxiaochu releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT guchristopher releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT venturajohnd releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT castillomenendezluis releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT melillobruno releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT terrydaniels releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT smithamosb releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT blanchardscottc releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT munrojamesb releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT motheswalther releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT finziandres releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins
AT sodroskijoseph releaseofgp120restraintsleadstoanentrycompetentintermediatestateofthehiv1envelopeglycoproteins